Debut is entering the professional beauty services market with its custom formulation and contract manufacturing business, BiotechXBeautyLabs; its first partner in the space is Formula Fig, with which the manufacturer will develop tech-enhanced beauty products that bridge the gap between beauty and medical aesthetics.
Among Formula Fig’s current offerings are injectables, facials and tech-enabled skin care treatments.
Read more: 6 Industry-changing Beauty Biotech Trends for 2024
According to Grand View Research, the global professional beauty services market was estimated at $247.24 billion in 2023 and is expected to grow at a CAGR of 7.0% by 2030. As consumers increasingly prioritize self-care and seek clinically backed beauty, biotech is poised to complement the assortment of aesthetic treatments offered by professional beauty services.
Joshua Britton, Ph.D., founder and CEO of Debut, says, "Debut has continually invested in its ability to find the highest-performing biotech ingredients that only we can access and now, through our groundbreaking business unit, BiotechXBeautyLabs, we are driving innovation in skin health for professional beauty services. Our recently signed partnership with Formula Fig underscores biotech's ability to deliver peak performance, clinical validation and superior claims. Our advances in skin biology and understanding of key areas such as aging and longevity means we can apply a scientific approach to creating solutions that have true credibility and align well with professional beauty services. We are thrilled to collaborate with Formula Fig which is fast-defining a unique position as an experiential, technology-driven skincare destination.”
Britton adds, "Professional beauty products need to be the exemplary standards of clinical beauty that is only possible with biotech. Consumers expect products that work at a clinical level otherwise they would simply purchase them online or in retail. The products that Debut’s BiotechXBeautyLabs develops in partnership with our professional clients are at the top end of biotech-enabled clinical performance. It is an intuitive fit to combine our advances in skin biology and biotech formulation expertise with an array of professional services. The products we develop for professional beauty do not contain biotech ingredients merely to support marketing claims. Rather, our biotech ingredients are used at clinically-tested concentrations."
Britton explains, "The novel claims that we are bringing into the professional channel are highly differentiated. We help med spas, skincare studios and facial bars reinforce the links between their desired claims and pure clinical results thanks to our proprietary biotech ingredients, and at a time when we are increasingly seeing the medicalization of beauty."
Britton concludes, "As a professional beauty service, you have two options: you can go the same-old route with a regular contract manufacturer that has the same ingredients as the one next door, or you can set yourself apart by partnering with BiotechXBeautyLabs and offer the highest-performing ingredients backed by science, and an exceptional R&D capability comprising 80 scientists. Experiential, tech-driven skincare destinations such as Formula Fig, who we are partnering with, are early adopters in post-treatment, biotech-enabled skincare and they are getting a powerful competitive advantage in the market. At the end of the day, it’s all about delivering enhanced results for consumers."
Jessica Walsh, founder and CEO of Formula Fig, says, "Collaborating with BiotechXBeautyLabs positions us alongside a partner equally committed to delivering scientifically-driven skincare solutions rooted in efficacy. With BiotechXBeautyLabs, we're developing products that perfectly complement our tech-enhanced, minimally invasive treatments, allowing guests to bring home the results of the treatment room. This collaboration fuels our ongoing mission to unite beauty with medical aesthetics, harnessing biotech to ensure our products and treatments are clinically validated, performance-focused, and accessible. With over 400,000 treatments behind us, we are excited to expand on this experience through our new skincare line launching next year.”
Britton concludes, "The scope and potential of biotech in professional beauty services is huge. If industry professionals want higher-performing formulations that deliver better results for their clients, then biotech is the easy answer.”
